211 related articles for article (PubMed ID: 31173237)
21. MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.
Song L; Xie X; Yu S; Peng F; Peng L
Mol Med Rep; 2016 Feb; 13(2):1204-10. PubMed ID: 26677064
[TBL] [Abstract][Full Text] [Related]
22. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
Zhang X; Jin K; Luo JD; Liu B; Xie LP
Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
[TBL] [Abstract][Full Text] [Related]
25. MiR-631/ZAP70: A novel axis in the migration and invasion of prostate cancer cells.
Fu D; Liu B; Zang LE; Jiang H
Biochem Biophys Res Commun; 2016 Jan; 469(3):345-51. PubMed ID: 26620225
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
Zhang W; Liu J; Qiu J; Fu X; Tang Q; Yang F; Zhao Z; Wang H
Oncol Rep; 2016 Dec; 36(6):3707-3715. PubMed ID: 27748848
[TBL] [Abstract][Full Text] [Related]
27. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
[TBL] [Abstract][Full Text] [Related]
31. miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
Huang YQ; Ling XH; Yuan RQ; Chen ZY; Yang SB; Huang HX; Zhong WD; Qiu SP
Mol Med Rep; 2017 Sep; 16(3):2431-2438. PubMed ID: 28677791
[TBL] [Abstract][Full Text] [Related]
32. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
33. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
34. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.
Bucay N; Sekhon K; Yang T; Majid S; Shahryari V; Hsieh C; Mitsui Y; Deng G; Tabatabai ZL; Yamamura S; Calin GA; Dahiya R; Tanaka Y; Saini S
Oncogene; 2017 May; 36(19):2667-2679. PubMed ID: 27893706
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.
Hu B; Jin X; Wang J
Oncol Res; 2018 Aug; 26(7):1093-1102. PubMed ID: 29321092
[TBL] [Abstract][Full Text] [Related]
38. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c.
Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B
Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526
[TBL] [Abstract][Full Text] [Related]
39. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
Chen W; Liu Y; Chen H; Ning H; Ding K
Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
[TBL] [Abstract][Full Text] [Related]
40. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]